In breast cancer, higher CD24 expression is significantly associated with a lower overall and disease-free survival rate, which suggests that CD24 is an efficient prognostic factor, closely related to clinicopathological factors, including lymph node infiltration and TNM staging [33]. This evidence concerns the gene CD24 and breast cancer.